期刊文献+

急性缺血性脑卒中静脉溶栓后出血性转化危险因素临床观察 被引量:4

Cl inical Observation on Risk Factors of hemorrhagic Transformation after intravenous Thrombolysis in Patients with acute ischemic Stroke
下载PDF
导出
摘要 目的分析急性缺血性脑卒中患者在静脉溶栓后发生出血转化与其预后的可能危险因素。方法选择2019年1月至2019年12月在庆阳市人民医院接受静脉溶栓治疗的40例急性缺血性脑卒中患者为研究对象,按照有无出血转化划分为观察组(15例,发生出血转化)和对照组(25例,未发生出血转化)。统计两组溶栓前后的NIHSS评分。结果本研究结果显示,观察组溶栓前及溶栓2 h后的NIHSS评分均显著高于对照组,差异显著(P<0.01)。结论在急性缺血性脑卒中静脉溶栓患者中,溶栓前和溶栓2 h后的NIHSS评分较高是出现出血性转化的危险因素,应做好针对性预防。 Objective To analyze the possible risk factors of hemorrhagic transformation and prognosis in patients with acute ischemic stroke after intravenous thrombolysis.Methods From January 2019 to December 2019,40 patients with acute ischemic stroke received intravenous thrombolytic therapy in Qingyang People's hospital,the patients were divided into observation group(15 cases,had hemorrhagic transformation)and control group(25 cases,had no hemorrhagic transformation).The NIHSS scores before and after thrombolysis were measured.Results The results showed that the NIHSS scores of the observation group were significantly higher than those of the control group(P<0.01).Conclusion Higher NIHSS scores before thrombolysis and 2 hours after thrombolysis are the risk factors of hemorrhagic transformation in patients with acute ischemic stroke,we should do a good job of targeted prevention.
作者 曹海莲 CAO Hailian(Qingyang People's Hospital,Qingyang Gansu 745000,China)
出处 《临床研究》 2021年第2期39-40,共2页 Clinical Research
关键词 急性缺血性脑卒中 静脉溶栓 出血性转化 危险因素 acute ischemic stroke intravenous thrombolysis hemorrhagic transformation risk factors
  • 相关文献

参考文献5

二级参考文献55

  • 1李小刚,张新宇,王力平,樊东升,孙阿萍,张远锦,郑梅.急性缺血性脑卒中rt-PA静脉溶栓后出血性转化的特殊类型[J].中国卒中杂志,2006,1(6):407-411. 被引量:1
  • 2张中银,谭琦,陈豪.急性脑梗死静脉溶栓的临床研究[J].卒中与神经疾病,2004,11(4):236-237. 被引量:2
  • 3董强.解读重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中临床应用共识[J].中华内科杂志,2006,45(12):1046-1047. 被引量:5
  • 4Lees KR, Bluhmki E, von Kummer K, Brott TG, Toni D, GrottaJC, A1 hers GW, Kaste M. Marler JR, Hamilton SA, Tilley BC,Davis SM. Donnan GA. Hatke W; FXASS. ATLANTIS, NINDSand EPITHET rt-PA Study Group; Allen K, Mau J, Meier D,del Zoppo G, !)e Silva DA, Butcher KS, Parsons MW, BarberPA. I.evi C, Bladin C, Byrnes G. Time lo treatment withintravenous allfplase ami outconit* in stroke: an updated pooledanalysis of ECASS, ATLANTIS, NINDS. and EPITHET trials.Lancet. 2010, 375:1695-1703.
  • 5Hackt* W. Kaste M, H1 u h m k i E, Brozman M, Devalos A,Guidetti D, Larrue V, Lees KK, Medeghri Z, Machnig T,Schneider I), von Kummer H. Wahlgren N. Toni D.Thromliolysis with alteplase 3 to 4.5 hours after acule ischemicstroke. N Engl J Med, 2008. 359:1317-1329.
  • 6Meretoja A. Putaala J. Tatlisumuk T, Alula S, Arlto V,.CurtzeS, Happolil 0, Lindsberg PJ, Mustanoja S, Piironen K,Pitkaniemi J, Rantanen K. Sairanen T, Salonen 0. SilvennoinenH, Soinne L, Strbian D, Tiainen M. Kaste M. Off - labelthrombolysis is not associated with poor outcome in patientswith stroke. Stroke, 2010, 41:1450-1458.
  • 7Lou M. Safdar A. Mehdiralta M, Kumar S, Schlaug G, CaplanL. Searls I). Selim M. The HAT Score: a simple grading scalefor predicting hemorrhage after thrombolysis. Neurology, 2008,71:1417-1423.
  • 8Strhian 0, Engeller S. Michel P, Meretoja A. Sekoranja L,Ahlhelni KJ, Muslanoja S. Kuzmanovic I,Sairanen T, Forss N,Cordier M, I.yrer P, Kaste M, Tatlisumak T. Symptomaticintracranial hemorrhage after stroke thrombolysis: ihe SEDANscore. Ann Neurol. 2012, 71:634-641.
  • 9Sharma VK, Ng KW, Venketasuhramanian N, Teoh HL, ChanBP. Intravenous thrombolysis for acute ischemic stroke in Asia.Expert Rev Neurother, 2012, 12:209-217.
  • 10Padma MV, Singh MB, Bhatia K, Srivastava A, Tripathi M,Shukla G,Goyul V, Singh S, Prasad K. Behari M.llyperacutethrombolysis with iv rtPA of acutt* ischemic stroke: efficacy andsafety profile of 54 patients at a tertiary referral center in adeveloping country. Neurol India, 2007. 55:46-49.

共引文献61

同被引文献46

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部